Improved tissue-engineered bone regeneration by endothelial cell mediated vascularization
Yu, Haiying VandeVord, Pamela J. Mao, Li Matthew, Howard W. Wooley, Paul H. Yang, Shang-You
Yu, Haiying
VandeVord, Pamela J.
Mao, Li
Matthew, Howard W.
Wooley, Paul H.
Yang, Shang-You
Citations
Altmetric:
Other Names
Location
Time Period
Advisors
Original Date
Digitization Date
Issue Date
2009-02
Type
Article
Genre
Keywords
Bone tissue engineering,Neovascularization,Endothelial cells,Bone marrow stromal cells,Polycaprolactone–hydroxyapatite composite
Subjects (LCSH)
Citation
Haiying Yu, Pamela J. VandeVord, Li Mao, Howard W. Matthew, Paul H. Wooley, Shang-You Yang, Improved tissue-engineered bone regeneration by endothelial cell mediated vascularization, Biomaterials, Volume 30, Issue 4, February 2009, Pages 508-517, ISSN 0142-9612, http://dx.doi.org/10.1016/j.biomaterials.2008.09.047. (http://www.sciencedirect.com/science/article/pii/S0142961208007217)
Abstract
Natural bone growth greatly depends on the precedent vascular network that supplies oxygen and essential nutrients and removes metabolites. Likewise, it is crucial for tissue-engineered bone to establish a vascular network that temporally precedes new bone formation, and spatially originates from within the graft. In order to recapitulate physiological skeletal development, we have developed a complex bone graft to repair rat bone defects. We have demonstrated that endothelial cells and osteoblasts (identified by cell morphology, quantification of specific marker antigens, calcium deposition and capillary-like growth) were able to differentiate and expand from donor rat bone marrow mononuclear cell populations. The biocompatibilities of poly-ɛ-caprolactone (PCL)-hydroxyapatite (HA) composites used for graft fabrication were evaluated at different component ratios to identify the optimal and support of cellular viability and functions for endothelial cells and osteoblasts. Using point-injection and low-pressure techniques, seeded endothelial cells and osteoblasts were able to assemble into microvascular networks and form bony matrix in grafts. The exogenous origination of these cells and their contribution to the vascularization and osteogenesis was confirmed using sex-mismatch implantation and Y chromosome tracking. By pre-seeding with endothelial cells, the resulting vascularization was able to promote osteogenesis, prevent ischemic necrosis and improve the mechanical properties in engineered bone tissue. Taken together, the results indicated that the integration of complex cell populations with composite scaffold materials provided an effective technique to improve osteogenesis in engineered bone graft. These findings suggest that hybrid grafts have great potential for clinical use to treat large bone defects.
Table of Contents
Description
Click on the DOI link to access this article
Publisher
Elsevier
Journal
Book Title
Series
Biomaterials;
;V.30, No.4
;V.30, No.4
Digital Collection
Finding Aid URL
Use and Reproduction
Archival Collection
PubMed ID
DOI
ISSN
0142-9612
1878-5905 (Electronic)
1878-5905 (Electronic)